Search Results

You are looking at 1 - 9 of 9 items for :

  • "glucagon-like peptide-1 receptor" x
  • All content x
Clear All
Open access

Emanuel Christ, Kwadwo Antwi, Melpomeni Fani, and Damian Wild

). Nevertheless, 18 F-DOPA PET showed a relatively high sensitivity in congenital hyperinsulinism and adult nesidioblastosis ( Stanley 2016 ). Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-1 receptor (GLP-1 R) A promising candidate is the

Free access

David A Pattison and Rodney J Hicks

include peptide receptors, such as the somatostatin receptor (SSTR) and glucagon-like peptide-1 receptor (GLP-1R), the amine precursor uptake and decarboxylation (APUD) system utilising the diphydroxyphenylaline (DOPA) analogue 6-[18F]- l -fluoro- l -3

Free access

Yuriko Mori, Alexandru V Olaru, Yulan Cheng, Rachana Agarwal, Jian Yang, Delgermaa Luvsanjav, Wayne Yu, Florin M Selaru, Susan Hutfless, Mark Lazarev, John H Kwon, Steven R Brant, Michael R Marohn, David F Hutcheon, Mark D Duncan, Ajay Goel, and Stephen J Meltzer

pooled control NCs was observed at 16 of the 20 analyzed loci: SFRP2 , visual system homeobox 2 ( VSX2 ), BEN domain containing 4 ( BEND4) , ALX homeobox 3 ( ALX3 ), neuronal pentraxin I ( NPTX1 ), glucagon-like peptide 1 receptor ( GLP1R ), homer

Free access

Roman Vangoitsenhoven, Chantal Mathieu, and Bart Van der Schueren

glucagon like peptide 1 receptors Gier et al . Waser et al . Körner et al . Human  Normal thyroid 5/15 (33%) 0/6 (0%) 1/18 (6%)  C-cell hyperplasia 9/9 (100%)  Papillary thyroid carcinoma 3/17 (18%)  Medullary thyroid carcinoma 11/12 (92%) 10/36 (28%) 5

Free access

Wouter W de Herder and Charis Eng

Vangoitsenhoven, Chantal Mathieu, and Bart van der Schueren discuss the benefits and potentially cancer-promoting risks of using the new incretin-based therapies, dipeptidyl peptidase-4 inhibitors, and glucagon-like peptide 1 receptor agonists for the treatment of

Free access

Jerena Manoharan, Max B Albers, and Detlef K Bartsch

pNENs of increased malignant potential ( Kornaczewski Jackson et al. 2017 ). This has to be confirmed in a large prospective observational study. Recent data suggest that glucagon-like peptide-1 receptor scintigraphy (GLP-1 scintigraphy) might be a

Free access

Jaap J M Teunissen, Dik J Kwekkeboom, R Valkema, and Eric P Krenning

peptide 1 receptor (GLP1R), which is expressed in very high density in almost all insulinomas ( Christ et al . 2009 ). Although the results with this compound are promising, most of the insulinomas are benign and localised (90%). Therefore, the need for

Free access

Georgios K Dimitriadis, Anna Angelousi, Martin O Weickert, Harpal S Randeva, Gregory Kaltsas, and Ashley Grossman

R Janota B Trofimiuk-Müldner M Przybylik-Mazurek E Hubalewska-Dydejczyk A 2013 Glucagon-like peptide-1 receptor imaging with [lys (40) (Ahx-HYNIC-(99m) Tc/EDDA)NH 2]-exendin-4 for the diagnosis of recurrence or dissemination of

Free access

Annemiek Walenkamp, Guillermo Crespo, Felipe Fierro Maya, Reidar Fossmark, Peter Igaz, Anja Rinke, Gianluca Tamagno, Giovanni Vitale, Kjell Öberg, and Tim Meyer

Reubi JC 2009 Glucagon-like peptide-1 receptor imaging for localization of insulinomas . Journal of Clinical Endocrinology and Metabolism 94 4398 – 4405 . ( doi:10.1210/jc.2009-1082 ). Cigrovski Berkovic M Catela Ivkovic T Marout J